Prokarium, Biotechnology and Biological Science Research Council, U.K. Technology Strategy Board (TSB), University of Birmingham infectious news

Prokarium and the university's Institute of Microbiology and Infection were awarded a £400,000 ($597,320) grant from the TSB and the BBSRC to fund the development of Prokarium's Vaxonella oral vaccine delivery technology as well as two vaccine candidates. The grant will allow Prokarium to complete preclinical work on Typhetec, a dual oral vaccine against typhoid and enterotoxigenic Escherichia coli (ETEC), and begin R&D on a vaccine against Clostridium difficile. The biotech and the university will also use the funding to test candidates that have the potential to be developed into oral vaccines. Prokarium was spun out of Cobra Biologics AB (Sodertalje, Sweden) in July 2011. ...